Rating History for Royalty Pharma (RPRX) by UBS
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
8/9/2023 | Ashwani Verma | Maintain | Buy (N/A) |
41.00 (44.00) |
|
Details | |
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
8/9/2023 | Ashwani Verma | Maintain | Buy (N/A) |
41.00 (44.00) |
|
Details | |